Franz-Josef Meyer-Almes

Prof. Dr. Franz-Josef Meyer-Almes

Chemical Engineering and Biotechnology, Darmstadt University of Applied Sciences, Darmstadt, Hesse, Germany
orcid

Research Focus & Metrics

Academic Career Length

34Years (1993-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 1993 in Biochemistry
Verified
Journal Article
Closed access
FMFranz-Josef Meyer-Almes
Franz-Josef Meyer-Almes
DPDietmar Porschke
Dietmar Porschke

27 July 2011 in Journal of Natural Products
Verified
Journal Article
Closed access
CWCheng Wang
Cheng Wang
LHLeonhard M. Henkes
Leonhard M. Henkes
LDLeah B. Doughty
Leah B. Doughty
MHMin He
Min He
DWDifei Wang
Difei Wang
YCYi-Qiang Cheng
Yi-Qiang Cheng

1 August 1998 in Journal of Biotechnology
Verified
Journal Article
Closed access
RRRudolf Rigler
Rudolf Rigler
Zeno Földes-PappZeno Földes-Papp
Zeno Földes-Papp
FMFranz-Josef Meyer-Almes
Franz-Josef Meyer-Almes
CSCyra Sammet
Cyra Sammet
MVMartin Völcker
Martin Völcker
ASAndreas Schnetz
Andreas Schnetz

31 October 2016 in ACS Infectious Diseases
Verified
Journal Article
Open access
CWClaire E. Weston
Claire E. Weston
AKAndreas Krämer
Andreas Krämer
FCFelix Colin
Felix Colin
ÖYÖzkan Yildiz
Özkan Yildiz
MBMatthias Bauer
Matthias Bauer
MFMatthew J. Fuchter
Matthew J. Fuchter
Photopharmacological agents exhibit light-dependent biological activity and may have potential in the development of new antimicrobial agents/modalities. Amidohydrolase enzymes homologous to the well-known human histone deacetylases (HDACs) are present in bacteria, including resistant organisms responsible for a significant number of hospital-acquired infections and deaths. We report photopharmacological inhibitors of these enzymes, using two classes of photoswitches embedded in the inhibitor pharmacophore: azobenzenes and arylazopyrazoles. Although both classes of inhibitor show excellent inhibitory activity (nM IC50 values) of the target enzymes and promising differential activity of the switchable E- and Z-isomeric forms, the arylazopyrazoles exhibit better intrinsic photoswitch performance (more complete switching, longer thermal lifetime of the Z-isomer). We also report protein–ligand crystal structures of the E-isomers of both an azobenzene and an arylazopyrazole inhibitor, bound to bacterial histone deacetylase-like amidohydrolases (HDAHs). These structures not only uncover interactions important for inhibitor binding but also reveal conformational differences between the two photoswitch inhibitor classes. As such, our data may pave the way for the design of improved photopharmacological agents targeting the HDAC superfamily.

1 October 1998 in Drug Discovery Today
Verified
Journal Article
Closed access
Manfred AuerManfred Auer
Manfred Auer
KMKeith J Moore
Keith J Moore
FMFranz-Josef Meyer-Almes
Franz-Josef Meyer-Almes
RGRolf Guenther
Rolf Guenther
APAndrew J Pope
Andrew J Pope
KSKurt A Stoeckli
Kurt A Stoeckli

15 June 2010 in PLOS ONE
Verified
Journal Article
Open access
PDF file
MHMichael Henkel
Michael Henkel
DMDavid Mitzner
David Mitzner
PHPeter Henklein
Peter Henklein
FMFranz-Josef Meyer-Almes
Franz-Josef Meyer-Almes
AMAnna Moroni
Anna Moroni
GTGerhard Thiel
Gerhard Thiel
PB1-F2 is a proapoptotic influenza A virus protein of approximately 90 amino acids in length that is located in the nucleus, cytosol and in the mitochondria membrane of infected cells. Previous studies indicated that the molecule destabilizes planar lipid bilayers and has a strong inherent tendency for multimerization. This may be correlate with its capacity to induce mitochondrial membrane depolarization. Here, we investigated whether PB1-F2 is able to form ion channels within planar lipid bilayers and microsomes. For that purpose, a set of biologically active synthetic versions of PB1-F2 (sPB1-F2) derived from the IAV isolates A/Puerto Rico/8/34(H1N1) (IAVPR8), from A/Brevig Mission/1/1918(H1N1) (IAVSF2) or the H5N1 consensus sequence (IAVBF2) were used. Electrical and fluorimetric measurements show that all three peptides generate in planar lipid bilayers or in liposomes, respectively, a barely selective conductance that is associated with stochastic channel type fluctuations between a closed state and at least two defined open states. Unitary channel fluctuations were also generated when a truncated protein comprising only the 37 c-terminal amino acids of sPB1-F2 was reconstituted in bilayers. Experiments were complemented by extensive molecular dynamics simulations of the truncated fragment in a lipid bilayer. The results indicate that the c-terminal region exhibits a slightly bent helical fold, which is stable and remains embedded in the bilayer for over 180 ns. The data support the idea that PB1-F2 is able to form protein channel pores with no appreciable selectivity in membranes and that the c-terminus is important for this function. This information could be important for drug development.